INDIANAPOLIS, May 29, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), ...
Skye’s CEO, CMO and CSO will be a featured panel session speakers at Evercore’s invitation-only event being held in conjunction with ADA.
Skye Bioscience, Inc., a clinical-stage biotechnology company focused on metabolic health, announced its participation in the American Diabetes Association's 85th Scientific Sessions, scheduled for ...
LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results